SINT:NASDAQ, Sintx Technologies, Inc.
SINT stock overview
Sintx Technologies, Inc. (SINT:NASDAQ) closed at $1.54 on November 9, 2026,
down 1.28% on the day.
The stock trades 65.5% below its 52-week high of $4.46
and 10.0% above its 52-week low of $1.40.
Over the past year, it lost 56.7%.
Sintx Technologies, Inc. is part of the Health Care sector (Medical/Dental Instruments).
Key figures
- Price
- $1.54
- Day change
- -1.28%
- Volume
- 41,133
- Average volume
- 116,835
- Market cap
- 11M+
- 52-week range
- $1.40 – $4.46
- 50-day average
- $1.80
- 200-day average
- $2.17
Price action over the past year
In 252 trading sessions since November 7, 2025, SINT closed higher on 107 days (42%).
Its best day was May 1, 2026 (+14.22%) and its worst was December 1, 2025 (-21.20%).
The stock moved 10% or more in a single session 11 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
SINT news
-
Nov 6, 2026:
SINTX Technologies Inc (SINT) (Q3 2026) Earnings Call Highlights: Record Revenue Surge and ...
-
Nov 5, 2026:
SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization
-
Oct 29, 2026:
SINTX Must Prove Its Doubled Revenue Forecast Reflects Durable Demand, Not A One-Off
-
Oct 22, 2026:
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast
-
Oct 8, 2026:
What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock
-
Oct 1, 2026:
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
-
Sep 14, 2026:
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
-
Sep 8, 2026:
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
About Sintx Technologies, Inc.
Amedica Corp is engaged in using its silicon nitride technology platform to develop, manufacture, and commercialize a variety of medical devices.
Similar stocks
Find more stocks like SINT with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.